Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BIIB - BIIB DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline


BIIB - BIIB DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline

  • Do you, or did you, own shares of Biogen Inc. (NASDAQ:BIIB)?
  • Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive?
  • Did you lose money in your investment in Biogen Inc.?
  • Do you want to discuss your rights?

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Biogen Inc. ("Biogen" or the "Company") (NASDAQ:BIIB) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

If you purchased or acquired Biogen securities, and/or would like to discuss your legal rights and options please visit Biogen Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.

A lawsuit was filed in the United States District Court for the District of Colorado on behalf of investors who purchased or acquired the securities of Biogen between February 3, 2022 and February 13, 2024, inclusive (the "Class Period"), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers.

If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2024 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco

Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
pallocco@bernlieb.com

SOURCE: Bernstein Liebhard LLP



View the original press release on accesswire.com

Stock Information

Company Name: Biogen Inc.
Stock Symbol: BIIB
Market: NASDAQ
Website: biogen.com

Menu

BIIB BIIB Quote BIIB Short BIIB News BIIB Articles BIIB Message Board
Get BIIB Alerts

News, Short Squeeze, Breakout and More Instantly...